billHR10145Event Monday, August 24, 2026Analyzed

SOUND Pesticide Research Act

Bearish

Summary

The SOUND Pesticide Research Act (HR10145) would require EPA to rely on multigenerational reproductive toxicity data for pesticide tolerance decisions, raising compliance costs for pesticide manufacturers ($CTVA, $FMC) and potentially boosting demand for contract research services ($CRL). The bill is in early stage with no cosponsors, so near-term market impact is minimal.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.Early-stage bill with low probability of near-term passage; no cosponsors.
  • 2.If enacted, would increase regulatory burden on pesticide manufacturers ($CTVA, $FMC) through mandatory multigenerational studies.
  • 3.Contract research organizations ($CRL) could benefit from increased demand for toxicology studies.

Market Implications

The bill is too early-stage to drive market moves. Pesticide companies ($CTVA, $FMC) trade on fundamentals and broader ag cycles, not on procedural bills. CROs ($CRL) are driven by biopharma R&D spending. Investors should watch for committee hearings or a Senate companion bill as triggers for re-evaluation.

Full Analysis

On August 24, 2026, Rep. Nancy Mace (R-SC) introduced H.R. 10145, the SOUND Pesticide Research Act, which was referred to the House Committee on Energy and Commerce. The bill amends the Federal Food, Drug, and Cosmetic Act to direct the EPA Administrator to rely on data from multigenerational reproductive toxicity studies (including at least four generations of test species) when establishing, modifying, or revoking tolerances or exemptions for pesticide chemical residues. The EPA must review existing tolerances within 180 days and report to Congress within two years.

The bill authorizes no direct funding; it imposes a regulatory mandate. Pesticide manufacturers will need to commission expensive, long-duration studies to support tolerance decisions, increasing their R&D costs and potentially delaying product approvals. This is a headwind for companies like Corteva ($CTVA) and FMC ($FMC), whose crop protection segments rely on EPA tolerances. Conversely, contract research organizations such as Charles River Laboratories ($CRL) that conduct these studies could see incremental demand. However, the bill is in an early legislative stage with zero cosponsors, making near-term passage unlikely. The legislative path requires committee markup, House floor vote, Senate companion, and presidential action—all uncertain.

No convergence signals were provided, so this bill stands alone. The primary market implication is that if the bill gains momentum, it would structurally increase regulatory costs for pesticide producers while benefiting CROs. For now, the impact is procedural and low.

Intelligence Surface

Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures

Unconfirmed

No confirming evidence found yet from contracts, insider trades, or congressional activity

$$CTVA▼ Bearish

What the bill does

Requires EPA to rely on multigenerational reproductive toxicity data (≥4 generations) for pesticide tolerance decisions

Who must act

Pesticide manufacturers seeking EPA tolerance or exemption for pesticide chemical residues

What happens

Increased cost and time to generate required study data for new and existing pesticide registrations

Stock impact

Corteva's crop protection segment will face higher R&D expenses and potential delays in product approvals, raising compliance costs

$$FMC▼ Bearish

What the bill does

Requires EPA to rely on multigenerational reproductive toxicity data (≥4 generations) for pesticide tolerance decisions

Who must act

Pesticide manufacturers seeking EPA tolerance or exemption for pesticide chemical residues

What happens

Increased cost and time to generate required study data for new and existing pesticide registrations

Stock impact

FMC's agricultural solutions segment will incur additional study costs and potential registration delays, impacting R&D budgets

Key Legislators

Rep. Mace, Nancy [R-SC-1]

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Exec OrderAug 6, 2026

Continuing to Protect the Meaning and Value of American Citizenship

This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.

Exec OrderAug 6, 2026

Ending Birth Tourism

This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →